These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1876600)

  • 1. Effect of a new synthetic protease inhibitor on beta-endorphin release during acute pancreatitis in dogs.
    Satake K; Hiura A; Ha SS; Nishiwaki H; Umeyama K
    Pancreas; 1991 Jul; 6(4):441-7. PubMed ID: 1876600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic effect of a new synthetic protease inhibitor (E-3123) on hemodynamic changes during experimental acute pancreatitis in dogs.
    Satake K; Ha SS; Hiura A; Nishiwaki H
    Gastroenterol Jpn; 1993 Feb; 28(1):64-71. PubMed ID: 8440425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bradykinin receptor antagonist on the release of beta-endorphin and bradykinin and on hemodynamic changes in a canine model of experimental acute pancreatitis.
    Satake K; Ha SS; Hiura A
    Pancreas; 1996 Jan; 12(1):92-7. PubMed ID: 8927625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma beta-endorphin and the effect of naloxone on hemodynamic changes during experimental acute pancreatitis in dogs.
    Satake K; Hiura A; Nishiwaki H; Ha SS; Chung YS; Umeyama K
    Surg Gynecol Obstet; 1989 May; 168(5):402-6. PubMed ID: 2540537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-3123, a new synthetic protease inhibitor, protects against deoxycholic acid-induced acute pancreatitis in dogs.
    Iwatsuki K; Horiuchi A; Yonekura H; Ren LM; Chiba S
    Arch Int Pharmacodyn Ther; 1990; 308():168-77. PubMed ID: 1711836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis.
    Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T
    Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs.
    Wakayama T; Itoh T; Shibayama K; Idezuki Y
    Am J Gastroenterol; 1989 Mar; 84(3):272-8. PubMed ID: 2465686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
    Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
    Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis.
    Hirano T; Manabe T
    J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal microcirculation in experimental acute pancreatitis of dogs.
    Nishiwaki H; Ko I; Hiura A; Ha SS; Satake K; Sowa M
    Ren Fail; 1993; 15(1):27-31. PubMed ID: 8441833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
    Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T
    Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].
    Miyamoto K; Hishinuma I; Nagakawa J; Nagaoka N; Yamanaka T; Wakabayashi T
    Nihon Yakurigaku Zasshi; 1988 May; 91(5):285-93. PubMed ID: 3410375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on hemodynamics of therapeutic infusion of gabexate mesilate (FOY) in experimental acute pancreatitis.
    Dobosz M; Sledziński Z; Basiński A; Stanek A; Babicki A; Wajda Z
    Res Exp Med (Berl); 1989; 189(2):77-84. PubMed ID: 2499022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307].
    Hirano T; Yotsumoto TM; Ando K; Tobe T
    Nihon Geka Hokan; 1991 Sep; 60(5):342-53. PubMed ID: 1726453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
    Hirano T; Manabe T; Tobe T
    Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Endorphin in canine hemorrhagic shock.
    Tuggle DW; Horton JW
    Surg Gynecol Obstet; 1986 Aug; 163(2):137-44. PubMed ID: 3016926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic antiproteases in acute pancreatitis: an experimental study.
    Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
    Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
    Hirano T; Manabe T
    Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of a cephalosporin, Shiomarin, plus a new potent protease inhibitor, E3123, on rat taurocholate-induced pancreatitis.
    Hirano T; Manabe T; Imanishi K; Tobe T
    J Gastroenterol Hepatol; 1993; 8(1):52-9. PubMed ID: 8439663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis.
    Hirano T; Manabe T; Tobe T
    Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.